The weekly litigation news digest is live. Subscribe now

IP Verse

Coherus BioSciences, Inc. v. AbbVie Biotechnology Ltd. et al. - IPR2017-01008

Explore the PTAB proceeding IPR2017-01008 filed by Coherus BioSciences, Inc. against AbbVie Biotechnology Ltd. et al. on Mar 2, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2017-01008
Filing Date
Mar 2, 2017
Petitioner
Coherus BioSciences, Inc.
Respondent
AbbVie Biotechnology Ltd. et al.
Status
Institution Denied
Respondent Application Number
14506576
Respondent Tech Center
1600
Respondent Patent Number
9085619
Institution Decision Date
Sep 7, 2017

Decision Documents New

Decision documents related to this case provide insights into the outcomes of proceedings. These documents are crucial for understanding the legal determinations and implications for the parties involved.

Document NameFiling DateCategoryFiling Party

Decision Denying Institution of Inter Partes Review

Sep 7, 2017PAPERBOARD

Counsels Involved New

Details of counsels involved in proceeding number IPR2017-01008.

TypeName
Petitioner CounselEDWARD FIGG
Respondent CounselAnthony Insogna

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Dec 1, 2017PAPERBOARD

Petitioner's Request for Refund of Post-Institution Fee

Nov 29, 2017PAPERPETITIONER

Decision Denying Institution of Inter Partes Review

Sep 7, 2017PAPERBOARD

Patent Owner's Preliminary Response

Jun 11, 2017PAPERPATENT OWNER

Wang 1999

Jun 11, 2017EXHIBITPATENT OWNER

Jorgensen 1996

Jun 11, 2017EXHIBITPATENT OWNER

Brazeau 1998

Jun 11, 2017EXHIBITPATENT OWNER

Kuzu 2001

Jun 11, 2017EXHIBITPATENT OWNER

Jorgensen 1994

Jun 11, 2017EXHIBITPATENT OWNER

Ipp 1989

Jun 11, 2017EXHIBITPATENT OWNER

Liu 2005

Jun 11, 2017EXHIBITPATENT OWNER

Veys 1997

Jun 11, 2017EXHIBITPATENT OWNER

Patent Owner's Updated Power of Attorney

Jun 11, 2017PAPERPATENT OWNER

Patent Owner's Updated Mandatory Notices

Jun 11, 2017PAPERPATENT OWNER

Coherus v AbbVie, IPR2016-01018, Exh 1002

Jun 11, 2017EXHIBITPATENT OWNER

Carpenter and Manning 2002

Jun 11, 2017EXHIBITPATENT OWNER

Chi 2003

Jun 11, 2017EXHIBITPATENT OWNER

Salinas 2010

Jun 11, 2017EXHIBITPATENT OWNER

Fayos 2005

Jun 11, 2017EXHIBITPATENT OWNER

Ruiz 2006

Jun 11, 2017EXHIBITPATENT OWNER

Chen 1994

Jun 11, 2017EXHIBITPATENT OWNER

Raibekas 2005

Jun 11, 2017EXHIBITPATENT OWNER

Gokarn 2008

Jun 11, 2017EXHIBITPATENT OWNER

USSN 14-879,847 - 4-21-17 Response to OA

Jun 11, 2017EXHIBITPATENT OWNER

USSN 14-643,844 - 8-24-15 Response to OA

Jun 11, 2017EXHIBITPATENT OWNER

Yu 1998

Jun 11, 2017EXHIBITPATENT OWNER

Lee 2013

Jun 11, 2017EXHIBITPATENT OWNER

Daugherty 2006

Jun 11, 2017EXHIBITPATENT OWNER

Kamerzell 2009

Jun 11, 2017EXHIBITPATENT OWNER

Helms 1995

Jun 11, 2017EXHIBITPATENT OWNER

Rouet 2014

Jun 11, 2017EXHIBITPATENT OWNER

Mezzasalma 2007

Jun 11, 2017EXHIBITPATENT OWNER

Carpenter 1997

Jun 11, 2017EXHIBITPATENT OWNER

Humphreys 2015

Jun 11, 2017EXHIBITPATENT OWNER

USSN 14-879,885 - 1-17-17 Pre-Appeal Brief

Jun 11, 2017EXHIBITPATENT OWNER

Barnett 1992

Jun 11, 2017EXHIBITPATENT OWNER

Shire 2015

Jun 11, 2017EXHIBITPATENT OWNER

ZEVALIN Label

Jun 11, 2017EXHIBITPATENT OWNER

Order Conduct of the Proceeding

Apr 7, 2017PAPERBOARD

Notice of Accord Filing Date

Mar 24, 2017PAPERBOARD

Patent Owner's Power of Attorney

Mar 23, 2017PAPERPATENT OWNER

Patent Owner's Mandatory Notices

Mar 23, 2017PAPERPATENT OWNER

Petitioner's Updated Mandatory Notices

Mar 23, 2017PAPERPETITIONER

PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619

Mar 2, 2017PAPERPETITIONER

Petitioner's Signed Power of Attorney

Mar 2, 2017PAPERPETITIONER

U.S. Patent No. 9,085,619, Fraunhofer et al.

Mar 2, 2017EXHIBITPETITIONER

U.S. Pub. No. 2016/0319011 (Gokarn '011)

Mar 2, 2017EXHIBITPETITIONER

Physicians Desk Reference (2003 Humira Label)

Mar 2, 2017EXHIBITPETITIONER

HUMIRA Label (Jan. 2008)

Mar 2, 2017EXHIBITPETITIONER

Annex A - The Humira Story

Mar 2, 2017EXHIBITPETITIONER

U.S. Pub. No. 2003/0206898, Fischkoff et al.

Mar 2, 2017EXHIBITPETITIONER

Parslow

Mar 2, 2017EXHIBITPETITIONER

Declaration of Klaus-Peter Radtke, Ph.D.

Mar 2, 2017EXHIBITPETITIONER

U.S. App. 60/690,582 to Gokarn (Gokarn Provisional)

Mar 2, 2017EXHIBITPETITIONER

Declaration of David D. Sherry, M.D.

Mar 2, 2017EXHIBITPETITIONER

Adalimumab Product Approval Information

Mar 2, 2017EXHIBITPETITIONER

Gokarn et al.

Mar 2, 2017EXHIBITPETITIONER

Gelfand

Mar 2, 2017EXHIBITPETITIONER

Fransson & Espander-Jansson

Mar 2, 2017EXHIBITPETITIONER

U.S. Pub. No. 2003/0138417, Kaisheva et al.

Mar 2, 2017EXHIBITPETITIONER

Laursen et al.

Mar 2, 2017EXHIBITPETITIONER

Nozaki & Tanford

Mar 2, 2017EXHIBITPETITIONER

Physicians Desk Reference (Gamimune Label)

Mar 2, 2017EXHIBITPETITIONER

Physicians Desk Reference (56th ed. 2002)

Mar 2, 2017EXHIBITPETITIONER

U.S. Pros. History of App. No. 13/774,735 - Part 1 of 2

Mar 2, 2017EXHIBITPETITIONER

Butler & Hamilton

Mar 2, 2017EXHIBITPETITIONER

Jefferis et al.

Mar 2, 2017EXHIBITPETITIONER

McDonnell

Mar 2, 2017EXHIBITPETITIONER

Christensen

Mar 2, 2017EXHIBITPETITIONER

Van Slyke

Mar 2, 2017EXHIBITPETITIONER

Frenken et al.

Mar 2, 2017EXHIBITPETITIONER

Olthuis et al.

Mar 2, 2017EXHIBITPETITIONER

U.S. Pros. History of App. No. 14/506,576

Mar 2, 2017EXHIBITPETITIONER

U.S. Pros. History of App. No. 13/774,735 - Part 2 of 2

Mar 2, 2017EXHIBITPETITIONER

U.S. Pros. History of App. No. 12/325,049 - Part 4 of 6

Mar 2, 2017EXHIBITPETITIONER

U.S. Pros. History of App. No. 12/325,049 - Part 1 of 6

Mar 2, 2017EXHIBITPETITIONER

U.S. Pros. History of App. No. 12/325,049 - Part 2 of 6

Mar 2, 2017EXHIBITPETITIONER

U.S. Pros. History of App. No. 12/325,049 - Part 3 of 6

Mar 2, 2017EXHIBITPETITIONER

U.S. Pros. History of App. No. 12/325,049 - Part 5 of 6

Mar 2, 2017EXHIBITPETITIONER

U.S. Prosecution History of App. No. 61/004,992

Mar 2, 2017EXHIBITPETITIONER

Schwartz

Mar 2, 2017EXHIBITPETITIONER

U.S. Pub. No. 2013/0273066

Mar 2, 2017EXHIBITPETITIONER

U.S. Pub. No. 2012/0028877

Mar 2, 2017EXHIBITPETITIONER

Gottlieb

Mar 2, 2017EXHIBITPETITIONER

U.S. Pros. History of App. No. 12/325,049 - Part 6 of 6

Mar 2, 2017EXHIBITPETITIONER

Stoner et al.

Mar 2, 2017EXHIBITPETITIONER

Fraunhofer Substantive Motion 3

Mar 2, 2017EXHIBITPETITIONER

U.S. Pub. No. 2004/0033535, Boyle et al.

Mar 2, 2017EXHIBITPETITIONER

Gebhart

Mar 2, 2017EXHIBITPETITIONER

Carnahan et al.

Mar 2, 2017EXHIBITPETITIONER

Press Release (Jan. 23, 2003)

Mar 2, 2017EXHIBITPETITIONER

U.S. Pub. No. 2008/0311078

Mar 2, 2017EXHIBITPETITIONER

WO 2006/138181, Gokarn et al.

Mar 2, 2017EXHIBITPETITIONER

U.S. Patent No. 6,090,382, Salfeld et al.

Mar 2, 2017EXHIBITPETITIONER

Affidavit of Marlene S. Bobka

Mar 2, 2017EXHIBITPETITIONER

Schwartzman & Morgan

Mar 2, 2017EXHIBITPETITIONER

Granolleras et al.

Mar 2, 2017EXHIBITPETITIONER

Annex to Note for Guidance on Development Pharmaceutics

Mar 2, 2017EXHIBITPETITIONER

Patent Owners Preliminary Response - IPR2016-01018

Mar 2, 2017EXHIBITPETITIONER

HUMIRA Label (Nov. 2015)

Mar 2, 2017EXHIBITPETITIONER

HUMIRA Label (Oct. 2016)

Mar 2, 2017EXHIBITPETITIONER

Vivaglobin Label (Jan. 2006)

Mar 2, 2017EXHIBITPETITIONER

GAMMAGARD LIQUID Label (April 2005)

Mar 2, 2017EXHIBITPETITIONER

Physicians Desk Reference entry for GAMUNEX (59th ed. 2005)

Mar 2, 2017EXHIBITPETITIONER

HepaGam Summary Basis for Approval (Jan. 2006)

Mar 2, 2017EXHIBITPETITIONER

TYSABRI Label (Nov. 2004)

Mar 2, 2017EXHIBITPETITIONER

Thomson Reuters (2016)

Mar 2, 2017EXHIBITPETITIONER

WO 1997/029131, Salfeld et al.

Mar 2, 2017EXHIBITPETITIONER

SYNAGIS Label (July 2004)

Mar 2, 2017EXHIBITPETITIONER

CNJ-016 (Vaccinia Immune Globulin Intravenous) Label (Jan. 2010)

Mar 2, 2017EXHIBITPETITIONER

Affidavit of Michael Deas

Mar 2, 2017EXHIBITPETITIONER

Flebogamma Label (Jan. 2004)

Mar 2, 2017EXHIBITPETITIONER

Privigen Label (Oct. 2016)

Mar 2, 2017EXHIBITPETITIONER

AVASTIN Label (Feb. 2004)

Mar 2, 2017EXHIBITPETITIONER

Vectibix Label (Sept. 2006)

Mar 2, 2017EXHIBITPETITIONER

Akers et al.

Mar 2, 2017EXHIBITPETITIONER

Hanna, The IGIV-C Study Group

Mar 2, 2017EXHIBITPETITIONER

Dean, Lange's Handbook of Chemistry

Mar 2, 2017EXHIBITPETITIONER

HUMIRA Label (Feb. 2008)

Mar 2, 2017EXHIBITPETITIONER

HUMIRA Label (Feb. 2007)

Mar 2, 2017EXHIBITPETITIONER

HUMIRA Label (Nov. 2006)

Mar 2, 2017EXHIBITPETITIONER

Meadows & Hollowell

Mar 2, 2017EXHIBITPETITIONER

ENBREL Label (Sept. 2002)

Mar 2, 2017EXHIBITPETITIONER

ENBREL Label (Nov. 1998)

Mar 2, 2017EXHIBITPETITIONER

REMICADE Label (Aug. 1998)

Mar 2, 2017EXHIBITPETITIONER

U.S. Patent No. 6,696,056, Cheung et al.

Mar 2, 2017EXHIBITPETITIONER

Campath Label (Aug. 2006)

Mar 2, 2017EXHIBITPETITIONER

Cleland & Langer

Mar 2, 2017EXHIBITPETITIONER

Rowe, Handbook of Pharmaceutical Excipients

Mar 2, 2017EXHIBITPETITIONER

Note for Guidance on Development Pharmaceutics

Mar 2, 2017EXHIBITPETITIONER

Affidavit of Christopher Butler

Mar 2, 2017EXHIBITPETITIONER

van de Putte, et al.

Mar 2, 2017EXHIBITPETITIONER

HUMIRA Label (Oct. 2005)

Mar 2, 2017EXHIBITPETITIONER

Tsourounis

Mar 2, 2017EXHIBITPETITIONER

Nash

Mar 2, 2017EXHIBITPETITIONER

Wang

Mar 2, 2017EXHIBITPETITIONER

U.S. Patent No. 9,114,166 to Krause et al.

Mar 2, 2017EXHIBITPETITIONER

Burton, D.R. et al

Mar 2, 2017EXHIBITPETITIONER

Yim, Summary Review for Regulatory Action

Mar 2, 2017EXHIBITPETITIONER